Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor

M. Aljurf, H. Al-Zahrani, M. T. Van Lint, J. R. Passweg

Research output: Contribution to journalArticle

Abstract

Matched related donor allo-SCT is the treatment of choice for patients with severe aplastic anemia (SAA) younger than 40 years of age. The standard conditioning regimen for such patients is cyclophosphamide with antithymocyte globulin. Unmanipulated BM is the best stem cell source for aplastic anemia patients going for SCT. Post-transplant GVHD prophylaxis with cyclosporine should be continued for 1 year. Early graft failure is rare but potentially life-threatening complication of SCT that can be managed with salvage SCT using more intense conditioning regimen.

Original languageEnglish
Pages (from-to)178-179
Number of pages2
JournalBone Marrow Transplantation
Volume48
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Aplastic Anemia
Siblings
Tissue Donors
Transplants
Antilymphocyte Serum
Cyclophosphamide
Cyclosporine
Stem Cells
Therapeutics
Conditioning (Psychology)

Keywords

  • aplastic anemia
  • identical sibling
  • transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor. / Aljurf, M.; Al-Zahrani, H.; Van Lint, M. T.; Passweg, J. R.

In: Bone Marrow Transplantation, Vol. 48, No. 2, 02.2013, p. 178-179.

Research output: Contribution to journalArticle

@article{2ed9b88096b84965beb290eb11606b4e,
title = "Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor",
abstract = "Matched related donor allo-SCT is the treatment of choice for patients with severe aplastic anemia (SAA) younger than 40 years of age. The standard conditioning regimen for such patients is cyclophosphamide with antithymocyte globulin. Unmanipulated BM is the best stem cell source for aplastic anemia patients going for SCT. Post-transplant GVHD prophylaxis with cyclosporine should be continued for 1 year. Early graft failure is rare but potentially life-threatening complication of SCT that can be managed with salvage SCT using more intense conditioning regimen.",
keywords = "aplastic anemia, identical sibling, transplantation",
author = "M. Aljurf and H. Al-Zahrani and {Van Lint}, {M. T.} and Passweg, {J. R.}",
year = "2013",
month = "2",
doi = "10.1038/bmt.2012.223",
language = "English",
volume = "48",
pages = "178--179",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor

AU - Aljurf, M.

AU - Al-Zahrani, H.

AU - Van Lint, M. T.

AU - Passweg, J. R.

PY - 2013/2

Y1 - 2013/2

N2 - Matched related donor allo-SCT is the treatment of choice for patients with severe aplastic anemia (SAA) younger than 40 years of age. The standard conditioning regimen for such patients is cyclophosphamide with antithymocyte globulin. Unmanipulated BM is the best stem cell source for aplastic anemia patients going for SCT. Post-transplant GVHD prophylaxis with cyclosporine should be continued for 1 year. Early graft failure is rare but potentially life-threatening complication of SCT that can be managed with salvage SCT using more intense conditioning regimen.

AB - Matched related donor allo-SCT is the treatment of choice for patients with severe aplastic anemia (SAA) younger than 40 years of age. The standard conditioning regimen for such patients is cyclophosphamide with antithymocyte globulin. Unmanipulated BM is the best stem cell source for aplastic anemia patients going for SCT. Post-transplant GVHD prophylaxis with cyclosporine should be continued for 1 year. Early graft failure is rare but potentially life-threatening complication of SCT that can be managed with salvage SCT using more intense conditioning regimen.

KW - aplastic anemia

KW - identical sibling

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=84873465632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873465632&partnerID=8YFLogxK

U2 - 10.1038/bmt.2012.223

DO - 10.1038/bmt.2012.223

M3 - Article

C2 - 23165494

AN - SCOPUS:84873465632

VL - 48

SP - 178

EP - 179

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 2

ER -